预emptive触珠蛋白对心脏手术患者术后急性肾损伤的影响:一项随机对照试验
这项单中心、开放标签随机对照试验在体外循环(CPB)下重大心血管手术患者中,以血清游离血红蛋白浓度0.05 g/dL为触发点,比较预emptive触珠蛋白治疗与标准治疗(溶血尿出现时给药)对术后48小时内肌酐变化(ΔCr)的影响。因患者安全顾虑提前终止,分析34例预emptive组和33例标准治疗组,预emptive组ΔCr中位数0.20(0.05-0.44)高于标准治疗组0.14(0.04-0.19)(P=.05)。多因素线性回归显示预emptive给药显著增加ΔCr(P=.03),提示预emptive触珠蛋白可能恶化肌酐值。
要点
- 预emptive触珠蛋白组ΔCr中位数0.20(0.05-0.44),高于标准治疗组0.14(0.04-0.19)。
- 多因素线性回归显示预emptive给药独立关联ΔCr增加(P=.03)。
- 因安全顾虑提前终止,样本量小,结论需谨慎解读。
核心结论
- 预emptive触珠蛋白给药恶化肌酐值,并独立关联ΔCr增加。
研究设计与样本
- 单中心、开放标签、随机对照试验,因安全顾虑提前终止。
- 最终分析预emptive组34例、标准治疗组33例。
主要发现
- 预emptive组ΔCr中位数0.20(0.05-0.44),标准治疗组0.14(0.04-0.19),P=.05。
- 多因素线性回归显示预emptive给药显著增加ΔCr(P=.03)。
关键数值与推荐
- 血清游离血红蛋白达0.05 g/dL时随机分组,预emptive组于CPB开始后2小时内给药4000 U。
- 标准治疗组在CPB开始后确认溶血尿时给予4000 U触珠蛋白。
- 主要结局为术前肌酐与术后48小时内最高肌酐差值(ΔCr)。
临床怎么用
- 预emptive触珠蛋白策略可能不改善术后肾功能,需重新评估其应用时机。
局限性
- 样本量小,因安全顾虑提前终止,统计效能有限。
- 开放标签设计可能引入偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Haptoglobin may reduce hemolysis-induced kidney injury in patients undergoing cardiovascular surgery with cardiopulmonary bypass (CPB). Haptoglobin may be given empirically when hemolytic urine is observed, or pre-emptively when detected by elevated free hemoglobin concentrations. In the present study, we investigated whether pre-emptive haptoglobin therapy guided by serum-free hemoglobin concentrations could prevent postoperative renal dysfunction in patients who underwent major cardiovascular surgery using CPB. METHODS: This study was a single-center, open-label, randomized controlled trial. Adult patients who underwent major cardiovascular surgery using CPB were included. Serum-free hemoglobin concentrations were measured in all patients who consented for this study. Patients with free hemoglobin concentrations that reached 0.05 g/dL were randomized to either (i) pre-emptive haptoglobin therapy group or (ii) standard of care group. Patients in the pre-emptive haptoglobin therapy group were administered 4000 U of haptoglobin when serum-free hemoglobin concentration reached 0.05 g/dL within 2 hours after the start of CPB. In the standard of care group, 4000 U of haptoglobin was administered when hemolytic urine was confirmed after the start of CPB. The primary outcome was the difference between the preoperative creatinine concentration and the maximum creatinine concentration within 48 hours after surgery (ΔCr). RESULTS: The study was terminated with the results of interim analysis due to patients' safety concerns. Finally, 34 patients in the pre-emptive haptoglobin therapy group and 33 in the standard of care group were included in the analysis. Median (interquartile range) ΔCr values were 0.20 (0.05-0.44) in the pre-emptive haptoglobin therapy group and 0.14 (0.04-0.19) in the standard of care group ( P = .05). Multiple linear regression analysis with ΔCr as objective variable and preoperative estimated glomerular filtration rate (eGFR), age, and randomize group as explanatory variables revealed that pre-emptive administration of haptoglobin significantly increased ΔCr ( P = .03). CONCLUSIONS: The interim study results demonstrated that in patients undergoing major cardiovascular surgery using CPB, pre-emptive haptoglobin administration worsened Cr values and independently associated with increased ΔCr.
引用
- Miyazaki A, Hokka M, Mizobuchi S, et al. Influence of Pre-emptive Haptoglobin on Postoperative Acute Kidney Injury in Cardiac Surgical Patients: A Randomized Controlled Trial. Anesth Analg. 2026. PMID: 41650332. doi:10.1213/ANE.0000000000007827
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。